PJL Life Sciences ApS: Financial statements 2025
CVR: 42773883
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PJL Life Sciences ApS (CVR 42773883) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 61,012 and a net result of DKK 46,736 compared with DKK 73,783 the year before. That is a decrease of 35.5% compared with the year before. Equity in the 2025 report amounted to DKK 259,830. The solvency ratio was 33.7%.
- Gross Profit
- DKK 61,012
- Profit/Loss
- DKK 46,736
- Equity
- DKK 259,830
- Total Assets
- DKK 771,179
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 61 t. | 47 t. | 260 t. | - |
| 2024 | - | 95 t. | 74 t. | 213 t. | - |
| 2023 | - | 45 t. | 35 t. | 139 t. | - |
Official annual report
How creditworthy is PJL Life Sciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PJL Life Sciences ApS has published its annual report for 2024. Gross profit came to DKK 94,573, and the net result was DKK 73,783.
About PJL Life Sciences ApS
PJL Life Sciences ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Philip Just Larsen. The company is owned by Philip Just Larsen. In 2025, the company reported a gross profit of DKK 61,012 and a net result of DKK 46,736 compared with DKK 73,783 the year before. Equity in the 2025 report amounted to DKK 259,830.